Hemorrhoidal Cream
NDC Package 69396-033-33

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Hemorrhoidal Cream (glycerol, phenylephine, pramoxine, petrolatum) cream is adults:When practical, clean the affected area by patting or blotting with an appropriate cleaning wipe. This formulation utilizes a cream delivery system. Marketed by Trifecta Pharmaceuticals Usa Llc, this product is identified by NDC 69396-033 and is authorized under FDA application M015.

Identification & Billing

NDC Package Code
69396-033-33
Package Description
3 TUBE in 1 BOX / 51 g in 1 TUBE
Product Code
69396-033
11-Digit Billing Format
69396003333
RxNorm Crosswalk
  • RxCUI: 1293649 - glycerin 14.4 % / phenylephrine HCl 0.25 % / pramoxine HCl 1 % / white petrolatum 15 % Rectal Cream
  • RxCUI: 1293649 - glycerin 144 MG/ML / petrolatum 150 MG/ML / phenylephrine hydrochloride 2.5 MG/ML / pramoxine hydrochloride 10 MG/ML Rectal Cream
  • RxCUI: 1293649 - glycerin 14.4 % / phenylephrine hydrochloride 0.25 % / pramoxine hydrochloride 1 % / white petrolatum 15 % Rectal Cream

Clinical Specifications

Proprietary Name
Hemorrhoidal Cream
Non-Proprietary Name
Glycerol, Phenylephine, Pramoxine, Petrolatum
Substance Name
Glycerin; Petrolatum; Phenylephrine Hydrochloride; Pramoxine Hydrochloride
Dosage Form
Cream - An emulsion, semisolid3 dosage form, usually containing > 20% water and volatiles5 and/or < 50% hydrocarbons, waxes, or polyols as the vehicle. This dosage form is generally for external application to the skin or mucous membranes.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
Pharmacologic Class
Usage Information
Adults:When practical, clean the affected area by patting or blotting with an appropriate cleaning wipe. Gently dry by patting or blotting with a tissue or soft cloth before applying cream.When first opening tube, puncture foil seal with top end of capApply externally or in the lower portion of the anal canal onlyApply externally to the affected area up to 4 times daily, especially at night, in the morning or after each bowel movement

Regulatory & Marketing

Labeler Name
Trifecta Pharmaceuticals Usa Llc
Product Type
Human Otc Drug
FDA Application #
M015
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
01-25-2019
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (69396-033). Click a package code to view its specific billing and regulatory data.

69396-033-18
1 TUBE in 1 BOX / 51 g in 1 TUBE
69396-033-22
2 TUBE in 1 BOX / 51 g in 1 TUBE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 69396-033-33 identifies a specific commercial package of 3 tube in 1 box / 51 g in 1 tube of Hemorrhoidal Cream, a human over the counter drug labeled by Trifecta Pharmaceuticals Usa Llc. This cream is formulated for topical use and contains glycerin; petrolatum; phenylephrine hydrochloride; pramoxine hydrochloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Trifecta Pharmaceuticals Usa Llc on January 25, 2019. The current certification is valid through December 31, 2026.

How is this Trifecta Pharmaceuticals Usa Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 69396003333. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
69396-033-33
11-Digit CMS (5-4-2)
69396-0033-33

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.